Research progress of azido-containing Pt(IV) antitumor compounds

Eur J Med Chem. 2022 Jan 5:227:113927. doi: 10.1016/j.ejmech.2021.113927. Epub 2021 Oct 16.

Abstract

Cancer is a long-known incurable disease, and the medical use of cisplatin has been a significant discovery. However, the side-effects of cisplatin necessitate the development of new and improved drug. Therefore, in this study, we focused on the photoactivatable Pt(IV) compounds Pt[(X1)(X2)(Y1)(Y2)(N3)2], which have a completely novel mechanism of action. Pt(IV) can efficiently overcome the side-effects of cisplatin and other drugs. Here, we have demonstrated, summarized and discussed the effects and mechanism of these compounds. Compared to the relevant articles in the literature, we have provided a more detailed introduction and a made comprehensive classification of these compounds. We believe that our results can effectively provide a reference for the development of these drugs.

Keywords: Anticancer; Diazido; Photoactivation; Prodrugs; Pt(IV).

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Azides / chemistry
  • Azides / pharmacology*
  • Cell Proliferation / drug effects
  • Drug Development
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Organoplatinum Compounds / chemistry
  • Organoplatinum Compounds / pharmacology*

Substances

  • Antineoplastic Agents
  • Azides
  • Organoplatinum Compounds